Form 4 Tracker
LEXICON PHARMACEUTICALS, INC.
LXRX

30 insider filings · Latest: May 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 25, 2026Feb 27 1:33 PMRaymond DebbaneDirector
Purchase
2,000$1.49$3.0K1,906,186(D)

View →

Feb 23, 2026Feb 25 12:00 PMRaymond DebbaneDirector
Purchase
100,000$1.47$147.0K1,904,186(D)

View →

Feb 20, 2026Feb 23 12:49 PMRaymond DebbaneDirector
Purchase
100,000$1.48$147.8K1,804,186(D)

View →

Feb 19, 2026Feb 23 12:49 PMRaymond DebbaneDirector
Purchase
50,000$1.44$72.0K1,704,186(D)

View →

Feb 18, 2026Feb 18 9:30 PMRaymond DebbaneDirector
Purchase
133,688$1.32$176.5K1,654,186(D)

View →

Feb 17, 2026Feb 18 9:30 PMRaymond DebbaneDirector
Purchase
76,857$1.31$100.5K1,520,498(D)

View →

Feb 13, 2026Feb 18 9:30 PMRaymond DebbaneDirector
Purchase
57,952$1.31$75.9K1,443,641(D)

View →

Feb 2, 2026Feb 4 9:25 PMInvus Global Management, LLCDirector, 10% Owner
Purchase
1,538,462$1.30$2.0M1,538,462(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 12, 2026Feb 17 9:08 PMSuma GopinathanSVP, Discovery
Grant/Award
596,130$1.37357,680(D)

View →

Feb 12, 2026Feb 17 9:07 PMLisa DefrancescoSVP, IR and Corp Comm
Grant/Award
643,830$1.37386,300(D)

View →

Feb 12, 2026Feb 17 9:07 PMBrian T CrumSVP, General Counsel & Secr.
Grant/Award
749,270$1.37449,560(D)

View →

Feb 12, 2026Feb 17 9:06 PMScott M CoianteSVP, Chief Financial Officer
Grant/Award
681,700$1.37409,020(D)

View →

Feb 12, 2026Feb 17 9:05 PMMichael ExtonDirector, Chief Executive Officer
Grant/Award
2,156,110$1.371,293,670(D)

View →

← Previous

Page 2 of 2